AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimikare-MSR 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Nitro Cadineur

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimikare-MSR 1mg/500mg Tablet

Glimikare-MSR 1mg/500mg tablets are classified as antidiabetic agents, a combination medication for managing type 2 diabetes in adults. This dual-action therapy helps regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor—lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a fast-acting glucose source like sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects encompass altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before initiating treatment. Pregnant or lactating individuals should seek medical advice before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended under your doctor's supervision.

Uses of Glimikare-MSR 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimikare-MSR 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimikare-MSR 1mg/500mg tablets should be administered with food.

Common Side effects of Glimikare-MSR 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimikare-MSR 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimikare-MSR 1mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Glimikare-MSR 1mg/500mg Tablet works:

Glimikare-MSR, a 1mg/500mg tablet, unites the antidiabetic actions of glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts triply: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol and Glimikare-MSR 1mg/500mg tablets should not be taken together due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimikare-MSR 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Using Glimikare-MSR 1mg/500mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Caution is advised when prescribing Glimikare-MSR 1mg/500mg tablets to individuals with impaired renal function; dosage modification may be necessary. Patients with severe kidney disease should not use Glimikare-MSR 1mg/500mg tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimikare-MSR 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In individuals with mild to moderate hepatic dysfunction, Glimikare-MSR 1mg/500mg tablets are typically initiated at a low dosage; however, their use is contraindicated in patients exhibiting severe liver disease.

What if you forget to take Glimikare-MSR 1mg/500mg Tablet :

Should you forget to take a Glimikare-MSR 1mg/500mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimikare-MSR 1mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimikare-MSR 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimikare-MSR 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Glimikare-MSR 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimikare-MSR 1mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged Glimikare-MSR 1mg/500mg Tablet use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Glimikare-MSR 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimikare-MSR 1mg/500mg tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimikare-MSR 1mg/500mg T...
34
MRP 42
19% off